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Health organizations claim that there should be ‘zero tolerance’ for counterfeit medicines, yet 
the problem is growing worldwide1-10. Labelling the tablet itself (“one-dose marking”), instead of 
package labelling, could be a powerful strategy to protect patients from fake drugs. 
Unfortunately, these methods are not in use today. This report proposes one viable solution: 
digitally encode polymers, which already form a major class of pharmaceutical excipients, and 
place them within tablets. Fluorescent polymer solutions can easily be electrospun into micron 
sized fibers and subsequently encoded by a photobleaching process. We have shown that, 
provided the physicochemical interactions between the fluorophore and the polymer are 
favourable, amorphous polymer fibers can be encoded with long lasting digital codes. Encoded 
fibers at the surface of tablets can be quickly decoded by using a basic fluorescence microscope. 
The materials and strategy used in this concept are simple and cheap, making it of special 
importance to patients in developing countries who now suffer or even die due to counterfeited 
medicines of inferior quality.  
 
Official health institutes recognize that drug counterfeiting is an ever increasing hazard to 
unaware consumers[1-10]. Especially considering the rising popularity of purchasing drugs via the 
internet, counterfeit drugs are becoming widespread[11, 12]. In industrialized countries, particularly 
today’s “lifestyle drugs” (e.g. sexual performance enhancers, smoking cessation agents) are targeted 
for easy profit. However, in developing countries antibiotics, painkillers, anti-malarial and HIV drugs 
are also being counterfeited. All too often, such counterfeits have caused patients’ deaths.   
To combat counterfeiting, the packaging of an increasing number of drugs is being  ‘protected’ 
by radio frequency tags, barcodes, watermarks, fluorescent inks, chemical or biological (DNA) tags[13]. 
Unfortunately, such tracking technologies are only effective if the drugs are not repackaged. 
Manufacturers often do not ship drugs directly to hospitals and dispensing pharmacies. Generally, 
drugs are sold to Wholesalers or Distributors who repackage drugs from bulk to unit-of-use containers 
which provide a means for counterfeit drugs to enter the legitimate drug supply chain. An authentic 
package does not therefore, certify authentic content.  To overcome this, “in-drug labelling” itself, 
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instead of on the drug packaging, could help defeat drug counterfeiters. Nowadays, the incorporation 
of taggants (like color-coded particles and mica particles coated with the colorants titanium oxide 
and/or iron oxide) in drug formulations is seldom used; one major reason being that it requires 
extensive toxicological screening of the taggant and formulation compatibility testing.  
 Tablets are the most widely used drug dosage form in the world. Recently we introduced 
digitally encoded polystyrene microparticles (named ‘memobeads’) for the in-product labeling of 
tablets[14-17]; information is written in the middle plane of fluorescently dyed microspheres by ‘spatial 
selective photobleaching’ of the fluorescence by the use of a confocal laser scanning microscope.  
‘On-tablet laser NanoEncryption’ was also announced, to write digital codes on the surface of 
tablets[18]. There has been also an interest in Raman spectroscopy to analyse the composition of the 
pharmaceutical excipients of a tablet[19]. Indeed, such an “excipient-fingerprint” could also be a tool to 
track down counterfeiters. Clearly, the future of Raman imaging of pharmaceutical excipients will 
need skilled personnel and expensive instruments, meanwhile, developing countries continue to suffer 
severely from counterfeited drugs.  
We took up this challenge; to “digitally encode polymers”, being the most widely used class of 
excipients in oral medicine, tablets, today. Our objective was to digitally encode polymers that are 
FDA approved for use in oral medicines, aiming to use them in trace amounts. Obviously, after 
encoding the polymers must remain harmless and decoding should occur by a fast, low-cost technique. 
This paper launches the concept of encoding a polymer by mixing the polymer solution with a 
fluorophore, electrospinning the solution into micron sized fibers and encoding the fibers by 
photobleaching. Two arguments explain our choice for electrospinning. Firstly, it is a remarkably 
simple technique that allows preparing the most simple polymeric matrices from a wealth of 
pharmaceutical polymers. Secondly, electrospinning allows aligning the microfibers which is a 
requirement when encoding the fibers by a scanning laser beam that locally destroys the fluorophores. 
Our reason for encoding the fibers by photobleaching was the observation that many polymers used in 
tablets form amorphous matrices with a rather high glass transition temperature (Tg), a request to get 
fluorophores sufficiently immobilized in the microfibers at room temperature. Keep in mind, mobile 
fluorophores would result in a recovery of the fluorescence in the bleached zones and thus a 
disappearance of the code. 
 We made use of a rotating wheel equipped with a glass support to collect the fluorescent fibers 
during the electrospinning process (Figure 1A). Highly aligned polystyrene (PS), ethylcellulose (EC), 
cellulose-acetate-phthalate (CAP), and poly(lactic-co-glycolic acid) (PLGA)-microfibers could be 
obtained by rotating the wheel at high speed. As Figure 2A illustrates, the higher the rotating speed, 
the better the fibers were aligned. 
Finding an optimal fluorophore was a challenge, as the dye should fulfill numerous 
requirements. a) It should sufficiently dissolve and be stable in the organic solvent(s) used to solve the 
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polymers. b) It should become sufficiently and homogenously encapsulated in the fibers. c) It should 
be strongly immobilized in the polymer matrix thereby obtaining a long-lasting code and to avoid 
losing dye into the water wherein the fiber pieces are dispersed to apply them to the tablets. d) The dye 
should bleach out from the intense laser beam of the encoding device. Finally, the fluorophore should 
be allowed to use in oral drugs.  
Fluorescein is a common water-soluble fluorophore.  Fluorescein capsules are taken by patients 
to diagnose ophthalmologic diseases[20, 21]. We loaded the fibers with the fluorescein derivative 
fluoresceinisothiocyanate (FITC), which is soluble in DMF and THF used to solve PS, EC, CAP and 
PLGA. Figure 2B1 shows that PS-fibers can be homogeneously loaded with FITC though, one day 
after keeping the fibers in open air at room temperature, FITC seems to have significantly migrated 
towards the surface of the fibers (Figure 2B2).  And especially upon dispersion in water, FITC 
significantly leaks from the fibers into the water (Figure 2B3). An insufficient immobilization of FITC 
in the PS-fiber and a too high solubility in water made FITC unsuitable. We continued with coumarin-
6. As Figures 2C2 and 2C3 show, even after 4 days’ storage in open air and after one day being 
dispersed in water, PS-fibers loaded with coumarin-6 remained homogeneously coloured. This was not 
only the case for PS-fibers, coumarin-6 seemed also well suited to design stable homogeneously 
coloured EC-, CAP- and PLGA-fibers (Figure 3 row A).    
The fabrication of small fiber pieces has recently received attention. In one method fiber pieces 
have been fabricated by the use of templates[21, 22]; in another study (long) fibers made by 
electrospinning were removed from the drum and cut by razor blades under liquid nitrogen into 50-
100µm rod-like pieces[23]. As Figure 3 panel B shows, a scanning UV laser could cut the aligned PS-, 
EC-, CAP- and PLGA-fibers into 100-200 µm long pieces. Figure 3 panel C shows that the coumarin-
6 loaded fiber pieces could be digitally encoded by photobleaching by a laser beam scanning along the 
longitudinal axis of the fiber pieces (Figure 1D). The encoded fiber pieces were named ‘memofibers’. 
For the purpose of this study a stable code is an absolute requirement. Clearly, the more mobile 
the fluorophore in the polymer fibers, the faster the digital code will disappear. If one assumed 
coumarin-6 diffusing in water, one could easily calculate from Stokes-Einstein law that it would take 
only seconds to travel a few micrometers. As the encoded segments are typically five to ten 
micrometers, it is a challenge to sufficiently immobilize the fluorophore in the fibers to avoid even the 
smallest displacement over the long term (months, years) the codes are expected to survive.  
Figure 3 panel E shows the contrast of the codes as a function of time. Clearly, in EC-fibers the 
code fades away over time. Although, in PS-, CAP- and PLGA-fibers the fluorescence recovery in the 
bleached segments is very weak keeping the codes clearly legible after 4 months’ storage. The reason 
the code in the EC-fibers disappears remains unknown. Calorimetric measurements revealed that the 
fibers showed a Tg of around 95 (PS) 133 (EC), 160 to 170 (CAP) and 50 °C (PLGA). All fibers were 
thus in amorphous state at room temperature. Very likely, a lower affinity between the fluorophore 
and the EC-matrix explains the fading of the codes in the EC-fibers.  
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 In the next step we evaluated whether the codes in fiber pieces deposited at the surface of tablets 
could be identified. Figure 3 panel D shows the fluorescence images we obtained from fibers at the 
surface of tablets using a simple fluorescence microscope. The digital codes are perfectly readable. 
Even after subjecting the tablets to a friability test the codes remained readable indicating that shear 
stresses do not detach memofibers from the tablets.    
 The concept of digitally encoding polymers by just mixing them with a fluorophore and 
spinning into simple fibers, then simply encoding them by spatial photobleaching, is especially 
attractive as it is broadly applicable to the wealth of polymers being used. With respect to the digital 
encoding of tablets, one could raise the question why memofibers should be preferred over 
memobeads which we introduced before[14, 17].   a) In memobeads the code is written in the central 
plane of polystyrene microspheres, requiring a proper orientation of the spheres for decoding. 
Therefore memobeads have to remain magnetic by adding ferromagnetic chromium dioxide particles. 
Due to the cylindrical geometry of the polymer fibers a proper orientation of the fibers is not necessary 
for decoding; regardless of the position of the fibers the codes are readable. b) Memofibers are simply 
composed of the pharmaceutical ingredient (i.e. the polymer) and a fluorophore while memobeads 
contain many more types of materials. Logically, the simpler the chemical composition, the easier it is 
to get the materials approved for use in medicines. We estimate that a 100 µm memofiber contains as 
little as 0.1 picogram coumarin-6; If we apply 10 fibers per tablet and assume a patient would take 10 
tablets a day, the daily intake of coumarin-6 would be around 10 picogram. An “impurity” in a drug 
formulation is allowed as long as the daily intake remains lower than 1.5 microgram[24]. c) Memofibers 
can be made from various types of pharmaceutical polymers, which is attractive considering the 
various polymers used in oral medicines. Designing memobeads from polymers other than polystyrene 
would be a huge challenge, to say the least.  d) As both the length and the thickness of memofibers can 
be easily controlled through appropriate spinning and cutting, it is very possible to store information in 
the length as well as the diameter of the memofibers. Changing the diameter of microspheres, and 
especially, making monodispers microspheres, remains a big technical challenge. Some other types of 
encoded cylindrically shaped geometries (rods) have been reported as well, however, those are all 
metal based (Al, Ni, Pd) rods[25, 26], which are not suited for the labeling of medicines. e) To decode 
memobeads they should be recovered from the tablets, whereupon one needs an expensive confocal 
fluorescence microscope and a magnetic field to read the code. Luckily, memofibers can be directly 
decoded at the tablet’s surface by a much cheaper fluorescence microscope.   
As Figure 4 shows, digital codes can be written in the polymer fibers of woven scaffolds too 
which are under investigation as e.g cell carriers for tissue engineering[27]. In such an “encoded web” 
the codes remain at fixed positions in space, thus allowing to identify positions in a three dimensional 
environment. The encoded-fiber-concept thus shows potential beyond the protection of 
pharmaceuticals against counterfeiting. As an example, one can imagine the loading of such webs with 
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different types of cells (or different types of bacteria) whereby the codes in the fibers allow to 
remember which type of cells (or bacteria) is present at a specific location. As another example,  fibers 
in such a web may be loaded with different types of bioactive compounds (like e.g. each fiber loaded 
with another growth factor) to be locally released to cells which are supported  by the web: the codes 
in the fiber may allow to identify to which types of drugs cells in specific areas of a web were 
exposed. 
In summary, this manuscript proposes to digitally encode oral medicines, in particular tablets 
containing drugs, using micron sized fibers made from pharmaceutical polymers, which are already a 
major class of excipients in oral drugs. We’ve shown that such memofibers can be readily obtained by 
electrospinning the polymer (PS, CAP and PLGA in this study, the two latter ones being frequently 
used in tablets[28] and subsequently cutting the long, aligned fibers into micrometer sized pieces using 
an appropriate scanning UV laser. Key to this concept is the immobilization of a fluorophore in glassy 
polymer fibers. Provided the glass transition temperature of the polymer fiber and the physicochemical 
interactions between the fluorophore and the polymer are favourable, we showed that the barcodes 
written in the fibers through photobleaching are stable over long periods. We’ve also provided 
evidence that memofibers at the tablet’s surface can be easily decoded using a basic fluorescence 
microscope, even without removing the fiber pieces from the tablets. This simple, inexpensive strategy 
makes the ‘digital encoded polymer fiber’ even more attractive for use in developing countries, 
especially where patients suffer and die from counterfeited medicines of inferior quality.   Nowadays 
“one-dose marking” is, to our knowledge, not in use; the major reasons being that a) only very 
recently have some technologies been proposed[14, 17, 18] and b) extensive toxicological screening and 
expensive formulation compatibility testing are needed in cases where taggants are added to these 
medicines. In our opinion, though highly advanced in use, the simple memofibers we presented will 
initiate the much needed solution to the in-product labelling of pharmaceuticals, especially as 
memofibers are made of those pharmaceutical ingredients having already been used for decades in 
tablets and other types of oral medicines.  
 
 Methods 
Microfibers were obtained by electrospinning polymer solutions containing a fluorophore (see Table 1 
in Supporting Information). An electrospinning setup (Figure 1A) requires a power supply, a syringe, 
a flat tip needle and a grounded collector[29]. A droplet of the polymer/fluorophore solution is formed 
at the tip of the needle by surface tension while charge is induced on the droplet surface by an electric 
field. When the electric field reaches a critical value at which the electric force overcomes the surface 
tension of the droplet, a charged jet is ejected from the tip. While the jet travels in air, the solvent 
evaporates, resulting in the deposition of fibers on a collector.  We used a rotating collector fitted with 
a glass support (Figure 1B) to collect aligned fibers.26 The fibers on the glass support were dried in 
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open air. As shown in Figure 1C, the aligned fluorescent fibers were cut into small pieces by cold 
ablation using a PALM MicroBeam System Version 4.0 AxioVert laser equipped with a 355 nm 
pulsed UV-Laser[30]
The fluorescent fiber pieces were encoded by spatial selective photobleaching by exposing well 
selected regions to a 488 nm laser beam (Figure 1D). An in-house-developed encoding device was 
used, being a laser scanning confocal microscope (Nikon) equipped with an argon laser and an 
acousto-optic modulator[15, 16, 31, 32]. Upon bleaching, the fluorescent molecules lose their fluorescence, 
giving rise to the code. The encoded fiber pieces (named ‘memofibers’) were dispersed in water, 
simply by applying a drop of water on the fiber pieces on the glass support.  
.  
Using a lactose/microcrystalline cellulose mixture 20 mm tablets were prepared. 2μl of a memofiber 
dispersion were dripped onto the surface of the tables (Figure 1E) and subsequently dried at 37oC for 
12h. For decoding, the surface of the tablets was imaged by a (non-confocal) fluorescence microscope. 
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Figure 1. Schematic representation of the synthesis of memofibers. A) Electrospinning setup. B) 
Aligned polymer fibers deposited by electrospinning on the glass support. C) Cutting of the polymer 
fibers into fiber pieces by cold ablation. D) Encoding of the fiber pieces by photobleaching through 
the use of a scanning laser beam. E) Applying a few microliters of a memofiber dispersion on the 
surface of a tablet.  
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Figure 2. Aligned fluorescent polymer fibers A) Transmission image of PS-fibers collected at 
different speeds of the rotating wheel (100 to 1200 rpm). B) Fluorescence images of aligned PS-fibers 
loaded with FITC: B1 - immediately after spinning, B2 - 1 day after keeping the fibers in open air at 
room temperature, B3 - 22 hours after dispersing the fibers in water; FITC significantly leaks from the 
fiber into the water (B3 is a combined transmission/fluorescence image as the fibers were no longer 
sufficiently fluorescent). C) same as for B but it concerns aligned PS-fibers loaded with coumarin-6. 
Scale bar is 100μm. 
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Figure 3. Fluorescence images of aligned fibers (A) and fiber pieces (B,C,D) loaded with coumarin-6. 
Note that information can be stored , not only in the width of the bars, but  as well in the length of the 
memofibers. The inserts in C and D show the barcodes which were written in the fiber pieces, the red 
rectangles indicate one memofiber. E) shows the contrast of the digital codes in the fiber pieces kept in 
open air at room temperature. The contrast of the code is defined as the ratio (%) of fluorescence in the 
bleached segments to the fluorescence in the non-bleached regions in the fiber. Scale bar is 100μm. 
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Figure 4. Digitally encoded polymer webs. Fluorescence images of non-aligned PS-fibers loaded with 
coumarin-6 and encoded by photobleaching. The middle and right panel are close-ups of the digital 
codes in the web. The scale bar is 50μm. 
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